Appl Environ Microbiol 2007, 73:3380–3390.CrossRefPubMed 39. Afset JE, Anderssen E, Bruant G, Harel J, Wieler L, Bergh K: Phylogenetic backgrounds and virulence profiles of atypical VX-661 supplier enteropathogenic Escherichia coli strains from a case-control study using multilocus sequence typing and DNA microarray analysis. J Clin Microbiol 2008, 46:2280–2290.CrossRefPubMed 40. Bielaszewska M, Middendorf B, Köck R, Friedrich AW, Fruth A, Karch H, Schmidt MA, Mellmann A: Shiga toxin-negative
attaching and effacing Escherichia coli : distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin Infect Dis 2008, 47:208–217.CrossRefPubMed 41. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673–4680.CrossRefPubMed 42. Gabastou JM, Kernéis S, Bernet-Camard MF, Barbat A, Coconnier MH, Kaper JB, Servin AL: Two stages of enteropathogenic Escherichia coli intestinal pathogenicity are up and down-regulated by the epithelial cell differentiation. Differentiation 1995, 59:127–134.CrossRefPubMed 43. Plancon L, Du Merle L, Le Friec S, Gounon P, Jouve M, Guignot J, Servin
A, Le Bouguenec C: Recognition of the cellular beta1-chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa-expressing pathogenic Escherichia coli strains. Cell Microbiol 2003, 5:681–693.CrossRefPubMed Staurosporine clinical trial 44. Pizarro-Cerdá J, Cossart P: Bacterial adhesion and entry into mafosfamide host cells. Cell 2006, 124:715–727.CrossRefPubMed 45. Kim K, Loessner MJ:Enterobacter sakazakii invasion in human intestinal Caco-2 cells requires
the host cell cytoskeleton and is enhanced by disruption of tight junction. Infect Immun 2008, 76:562–570.CrossRefPubMed 46. Grützkau A, Hanski C, Hahn H, Riecken EO: Involvement of M cells in the bacterial invasion of Peyer’s patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 1990, 31:1011–1015.CrossRefPubMed 47. McCormick BA, Parkos CA, Colgan SP, Carnes DK, Madara JL: Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. J Immunol 1998, 160:455–466.PubMed 48. McNamara BP, Koutsouris A, O’Connell CB, Nougayréde JP, Donnenberg MS, Hecht G: Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest 2001, 107:621–629.CrossRefPubMed 49. Peralta-Ramírez J, Hernandez JM, Manning-Cela R, Luna-Muñoz J, Garcia-Tovar C, Nougayréde JP, Oswald E, Navarro-Garcia F: EspF Interacts with nucleation-promoting factors to mTOR inhibitor recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Infect Immun 2008, 76:3854–68.